Search Results 381-390 of 13896 for SC

  1. Irritable bowel syndrome - Doctors and departments - Mayo Clinic

    Camilleri, Michael M.D., D.Sc. Minnesota. DiBaise, John K. M.D.. Arizona. Farrugia, Gianrico M.D.. Minnesota. Fox, Jean C. M.D.. Minnesota. Grover, Madhusudan ...

  2. Gastroenterology and Hepatology - Clinical trials

    SC nivolumab in-home treatment may be safe, tolerable and/or effective when compared to in-clinic treatment and may reduce the burden of cancer and improve ...

  3. YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma - Mayo Clinic

    ... SC every 3 weeks in patients with advanced or metastatic sarcoma who are refractory to or intolerant to other available therapies. Also, to evaluate safety ...

  4. Collaborators - Vaccines: Gregory A. Poland, Richard B. Kennedy - Mayo Clinic Research

    Pandey, M.D.; Medical University of South Carolina; Charleston, South ... Jennifer Whitaker, M.D., M.Sc. Baylor College of Medicine; Houston, Texas.

  5. A Study To Evaluate If Benralizumab Compared To Mepolizumab May Be Beneficial In The Treatment Of Eosinophilic Granulomatosis With Polyangiitis (EGPA) - Mayo Clinic

    ... (SC) injection every 4th week in patients with relapsing or refractory EGPA on corticosteroid therapy with or without stable immunosuppressive therapy. All ...

  6. Otolaryngology (ENT)/Head and Neck Surgery - Clinical trials

    SC nivolumab in-home treatment may be safe, tolerable and/or effective when compared to in-clinic treatment and may reduce the burden of cancer and improve ...

  7. A Study To Examine The Long-Term Safety, Tolerability And Effectiveness Of APL-130277 For The Acute Treatment Of "OFF" Episodes In Patients With Parkinson's Disease - Mayo Clinic

    Treatment with any form of s.c. apomorphine within 7 days prior to the initial Screening Visit (SV1). Patients that stopped s.c. apomorphine for any reason ...

  8. Gastroenterology and Hepatology - Clinical trials

    SC nivolumab in-home treatment may be safe, tolerable and/or effective when compared to in-clinic treatment and may reduce the burden of cancer and improve ...

  9. Safety Study Of OA-235i In Subjects With Nonalcoholic Steatohepatitis - Mayo Clinic

    ... (sc) to adult subjects with suspected or confirmed diagnosis of noncirrhotic nonalcoholic steatohepatitis (NASH) with no fibrosis to moderate fibrosis ...

  10. Publications - Laura E. Breeher, M.D., M.P.H. - Mayo Clinic

    ... SC. A Multisite Assessment of Inpatient Safety Event Rates During the Coronavirus Disease 2019 Pandemic. Mayo Clin Proc Innov Qual Outcomes. 2023 Feb; 7 (1): ...